Shopping Cart 0
Cart Subtotal
AED 0

North America Injectable Drug Delivery Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 9175

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 11744
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

North America injectable drug delivery market is expected to reach USD 475,824.35 million by 2025 from USD 173,547.84 million in 2017, at a CAGR of 11.7% in the forecast period 2018 to 2025.

The major factors contributing to the growth of the market includes factors such rising cases of chronic diseases and due to rising demand of self-injection devices. On the other hand needle stick injuries and infections may hinder the growth of the market.

The key market players for North America injectable drug delivery market are listed below:

Baxter International, Inc.,

Becton Dickinson and Company,

Gerresheimer AG,

Pfizer, Inc.,

Schott AG,

Alkermes Plc.,

Eli Lilly and Company,

Sandoz,

Terumo Corporation,

Teva Pharmaceuticals Industries Ltd.

Ypsomed,

Bespak

The market is further segmented into:

Type

Usage Pattern

End-User

Mode of Administration

Distribution Channel

Application

Geography

The North America injectable drug delivery market is segmented on of type, portability, type, product type, application, and usage pattern, mode of administration, end user, distribution channel, and geography. The report provides data for 2016 to 2025, 2017 being the current year while 2018 to 2025 is the forecast period for the report.

The North America injectable drug delivery market is segmented based on type into two notable segments; injectable drug delivery device and injectable drug delivery formulation. Injectable drug delivery device market is segmented into conventional injection devices and self-injection devices. The injectable drug delivery formulation is segmented into conventional drug delivery formulation and novel drug delivery formulation. The Injectable drug delivery market is dominated by formulations with 67.3% market share in 2018, growing at a CAGR of 11.7% and will cross USD 321,636.51 million by 2025.

On the basis of application, the market is segmented into autoimmune disease, hormonal disorders, orphan diseases, oncology and others. The autoimmune diseases segment is further sub segmented based on indications into rheumatoid arthritis, multiple sclerosis, Crohn's disease, psoriasis and others. Hormonal disorders are further segmented into indications such as diabetes, antithrombotic therapy, reproductive health diseases, anemia, osteoporosis and others. The Injectable drug delivery market is dominated by hormonal disorders with 51.3% market share in 2018, growing at a CAGR of 11.6% and will cross USD 243,167.7 million by 2025. However, oncology segment is expected to grow at the highest CAGR of 12.7% in the forecast period, and is expected to reach USD 121,443.5 million in 2025 from USD 40,516.7 million in 2017.

On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern. The Injectable drug delivery market is dominated by curative care with 91.7% market share in 2018, growing at a CAGR of 11.8% and will cross USD 440,541.8 million by 2025.

On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system. The Injectable drug delivery market is dominated by skin with 43.2% market share in 2018, growing with highest CAGR of 12.3% and will cross USD 215,342.4 million by 2025.

On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others. The Injectable drug delivery market is dominated by hospitals & clinics with 64.6% market share in 2018, growing at a CAGR of 11.7% and will cross USD 307,853.9 million by 2025. However, home healthcare settings companies segment is expected to grow at the highest CAGR of 12.3% in the forecast period, and is expected to reach USD 113,830.3 million in 2025 from USD 39,257.1 million in 2017

On the basis of distribution channel, the market is classified into hospital pharmacies, pharmacy store, and direct tender and online pharmacy. The Injectable drug delivery market is dominated by direct tenders with 65.1% market share in 2018, growing the highest CAGR of 11.9% and will cross USD 315,277.4 million by 2025.

Based on geography, the North America injectable drug delivery market is segmented into geographical regions, such as

U.S.

Canada

Mexico

Covered in this report

The report covers the present scenario and the growth prospects of the North America injectable drug delivery market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report

READ MORE

Table Of Content

Scope

Table Of Contents

1 Introduction 21

1.1 Overview Of North America Injectable Drug Delivery Market 21

1.2 Currency And Pricing 22

1.3 Limitation 22

1.4 Markets Covered 23

2 Market Segmentation 26

2.1 Markets Covered 26

2.2 Geographic Scope 27

2.3 Years Considered For The Study 28

2.4 Currency And Pricing 28

2.5 Research Methodology 29

2.6 Primary Interviews With Key Opinion Leaders 32

2.7 Secondary Sources 33

2.8 Assumptions 33

3 Market Overview 34

3.1 Drivers 36

3.1.1 Rising Cases Of Chronic Diseases 36

3.1.2 Rising Demand Of Self-Injection Devices 38

3.1.3 Growth Of Biologics Market 38

3.1.4 Technological Advancements And Innovations In Drug Delivery Market 39

3.2 Restraints 40

3.2.1 Needlestick Injuries And Infections 40

3.2.2 High Cost Of Development 41

3.2.3 Strict Regulatory Framework 42

3.3 Opportunity 43

3.3.1 Increasing Demand For Generic And Biosimilar Drugs 43

3.3.1.1 Generics 43

3.3.1.2 Biosimilars 43

3.3.2 Increasing Demand For Contraceptive Injectables 44

3.3.3 Increasing Demand For Self-Administration Of Drugs 45

3.4 Challenges 46

3.4.1 Alternative Route Of Drug Administration 46

3.4.2 Product Recall 47

3.4.3 Stability Of Products 47

3.4.4 Sterility Of Injections 48

4 Executive Summary 49

5 Premium Insights 51

6 North America Injectable Drug Delivery Market, By Type 54

6.1 Overview 55

6.2 Injectable Drug Delivery Devices 56

6.2.1 Conventional Injection Devices 57

6.2.1.1 Conventional Injection Devices, By Material 59

6.2.1.1.1 Glass 59

6.2.1.1.2 Plastic 59

6.2.1.2 Conventional Injection Devices, By Product 60

6.2.1.2.1 Fillable Syringes 60

6.2.1.2.2 Prefilled Syringes 61

6.2.1.3 Conventional Injection Devices, By Usability 62

6.2.1.3.1 Reusable Syringes 62

6.2.1.3.2 Disposable Syringes 62

6.2.2 Self Injection Devices 63

6.2.2.1 Needle Free Injectors (Nfi) 64

6.2.2.2 Needle Free Injectors, By Product 65

6.2.2.2.1 Fillable Needle-Free Injectors 65

6.2.2.2.2 Prefilled Needle-Free Injectors 65

6.2.2.3 Needle Free Injectors, By Technology 66

6.2.2.3.1 Jet Based Needle Free Injectors: 66

6.2.2.3.2 Spring Based Needle Free Injectors: 67

6.2.2.3.3 Laser Based Needle Free Injectors: 67

6.2.2.3.4 Vibration Based Needle Free Injectors: 67

6.2.2.4 Needle Free Injectors, By Usability 68

6.2.2.4.1 Reusable Needle-Free Injectors 68

6.2.2.4.2 Disposable Needle-Free Injectors 68

6.2.2.5 Auto Injectors 69

6.2.2.6 Auto Injectors, By Product 70

6.2.2.6.1 Fillable Auto Injectors 70

6.2.2.6.2 Pre-Filled Autoinjectors 70

6.2.2.7 Auto Injectors, By Technology 71

6.2.2.7.1 Automated Auto Injectors 71

6.2.2.7.2 Manual Auto Injectors 71

6.2.2.8 Auto Injectors, By Design 73

6.2.2.8.1 Standardized Auto Injectors 73

6.2.2.8.2 Automated Autoinjectors 73

6.2.2.9 Auto Injectors, By Usability 74

6.2.2.9.1 Reusable Autoinjectors 74

6.2.2.9.2 Disposable Autoinjectors 74

6.2.2.10 Pen Injectors 75

6.2.2.11 Pen Injectors, By Product 75

6.2.2.11.1 Single Chambered Pen Injectors 75

6.2.2.11.2 Dual Chambered Pen Injectors 76

6.2.2.12 Pen Injectors, By Design 76

6.2.2.12.1 Standard Pen Injectors 76

6.2.2.12.2 Customized Pen Injectors 77

6.2.2.13 Pen Injectors, By Usability 77

6.2.2.13.1 Reusable Pen Injectors 77

6.2.2.13.2 Disposable Pen Injectors 78

6.2.2.14 Wearable Injectors 78

6.2.2.14.1 Other Devices 79

6.3 Injectable Drug Delivery Formulation 80

6.3.1 Conventional Drug Delivery Formulations 81

6.3.1.1 Solutions 81

6.3.1.2 Reconstituted/Lyophilized Formulations 81

6.3.1.3 Suspensions 82

6.3.1.4 Emulsions 83

6.3.2 Novel Drug Delivery Formulations 85

6.3.2.1 Colloidal Dispersions 86

6.3.2.1.1 Niosomes 86

6.3.2.1.2 Liposomes 87

6.3.2.1.3 Polymeric Mixed Micelles 88

6.3.2.1.4 Nanoparticles 89

6.3.2.1.5 Nanosuspensions 89

6.3.2.1.6 Nanoemulsions/Microemulsions 90

6.3.2.1.7 Solid Lipid Nanoparticles 91

6.3.2.2 Microparticles 92

6.3.2.2.1 Microspheres 92

6.3.2.2.2 Microcapsules 93

6.3.2.3 Long Acting Injection Formulation 94

?

7 North America Injectable Drug Delivery Market, By Application 96

7.1 Overview 97

7.2 North America Injectable Drug Delivery Market, By Application 98

7.3 Hormonal Disorders 99

7.3.1 Injectable Drugs For Diabetes 99

7.3.2 Injectable Drugs For Anemia 100

7.3.3 Injectable Drugs For Reproductive Health Disease 102

7.3.4 Injectable Drugs For Antithrombotic/Thrombolytic Therapy 103

7.3.5 Injectable Drugs For Osteoporosis 103

7.3.6 Injectable Drugs For Growth Hormone Disorders (Ghd) 104

7.4 Oncology 106

7.5 Autoimmune Diseases 108

7.5.1 Injectable Drugs For Rheumatoid Arthritis 108

7.5.2 Injectable Drugs For Multiple Sclerosis 109

7.5.3 Injectable Drugs For Crohn'S Diseases 110

7.5.4 Injectable Drugs For Psoriasis 111

7.5.5 Injectable Drugs For Other Autoimmune Diseases 112

7.6 Orphan Disease 113

7.7 Other Applications 115

7.7.1 Injectable Drugs For Pain Management 115

7.7.2 Injectable Drugs For Allergy Treatment 116

7.7.3 Injectable Drugs For Aesthetic Treatments 117

7.7.4 Injectable Drugs For Hepatitis C 118

7.7.5 Injectable Drugs For Hemophilia 119

8 North America Injectable Drug Delivery Market, By Usage Pattern 121

8.1 Overview 122

8.2 Curative Care 123

8.3 Immunizations 124

8.4 Other Usage Pattern 125

9 North America Injectable Drug Delivery Market, By Mode Of Administration 126

9.1 Overview 127

9.2 Skin 128

9.3 Circulatory/ Muskoskeletal 128

9.4 Organs 129

9.5 Central Nervous System 130

?

10 North America Injectable Drug Delivery Market, By End User 131

10.1 Overview 132

10.2 Hospitals And Clinics 134

10.3 Home Healthcare Settings 134

10.4 Research Laboratories 134

10.5 Pharmaceutical And Biotechnological Companies 135

10.6 Other End Users 136

11 North America Injectable Drug Delivery Market, By Distribution Channel 137

11.1 Overview 138

11.1.1 Hospital Pharmacy 139

11.1.2 Pharmacy Stores 139

11.1.3 Direct Tender 139

11.1.4 Online Pharmacy 139

12 North America Injectable Drug Dilivery Market By Geography 141

12.1.1 U.S. Injectable Drug Delivery Market 158

12.1.2 Canada Injectable Drug Delivery Market 173

12.1.3 Mexico Injectable Drug Delivery Market 189

13 North America Injectable Drug Delivery Market, Company Share 205

13.1 Company Share Analysis: North America 205

14 Company Profiles 206

14.1 Becton, Dickinson And Company 206

14.1.1 Company Overview 206

14.1.1.1 Drivers Explained 207

14.1.1.2 Weaknesses Explained 207

14.1.1.3 Oppurtunities Explained 208

14.1.1.4 Threats Explained 208

14.1.2 Product Portfolio 209

14.1.3 Recent Developments 210

14.2 Pfizer 211

14.2.1 Company Overview 211

14.2.1.1 Drivers Explained 212

14.2.1.2 Weaknesses Explained 213

14.2.1.3 Oppurtunities Explained 213

14.2.1.4 Threats Explained 214

14.2.2 Product Portfolio 215

14.2.3 Recent Developments 216

14.3 Baxter International 217

14.3.1 Company Overview 217

14.3.1.1 Drivers Explained 218

14.3.1.2 Weaknesses Explained 219

14.3.1.3 Oppurtunities Explained 219

14.3.1.4 Threats Explained 220

14.3.2 Product Portfolio 221

14.3.3 Recent Developments 222

14.4 Gerresheimer Ag 223

14.4.1 Company Overview 223

14.4.2 Product Portfolio 224

14.4.3 Recent Developments 224

14.5 Schott Ag Inc. 225

14.5.1 Company Overview 225

14.5.2 Product Portfolio 226

14.5.3 Recent Developments 226

14.6 Alkermes Inc. 227

14.6.1 Company Overview 227

14.6.2 Product Portfolio 228

14.6.3 Recent Developments 228

14.7 Antares Pharma 229

14.7.1 Company Overview 229

14.7.2 Product Portfolio 230

14.7.3 Recent Developments 230

14.8 Bespak (Subsidiary Of Consort Medical Company) 232

14.8.1 Company Overview 232

14.8.2 Product Portfolio 233

14.8.3 Recent Developments 233

14.9 Elcam Medical 234

14.9.1 Company Overview 234

14.9.2 Product Portfolio 234

14.9.3 Recent Developments 234

14.10 Eli Lilly And Company 235

14.10.1 Company Overview 235

14.10.1.1 Drivers Explained 236

14.10.1.2 Weaknesses Explained 237

14.10.1.3 Oppurtunities Explained 237

14.10.1.4 Threats Explained 238

14.10.2 Product Portfolio 239

14.10.3 Recent Developments 240

14.11 Haselmeier 241

14.11.1 Company Overview 241

14.11.2 Product Portfolio 241

14.11.3 Recent Developments 242

14.12 Mylan N.V. 243

14.12.1 Company Overview 243

14.12.2 Product Portfolio 243

14.12.3 Recent Developments 244

14.13 Novo Nordisk 245

14.13.1 Company Overview 245

14.13.2 Product Portfolio 246

14.13.3 Recent Developments 247

14.14 Owen Mumford Ltd 248

14.14.1 Company Overview 248

14.14.2 Product Portfolio 249

14.14.3 Recent Developments 249

14.15 Sandoz International Gmbh 250

14.15.1 Company Overview 250

14.15.2 Product Portfolio 251

14.15.3 Recent Developments 251

14.16 Sanofi 252

14.16.1 Company Overview 252

14.16.2 Product Portfolio 253

14.16.3 Recent Developments 254

14.17 Terumo Corporation 255

14.17.1 Company Overview 255

14.17.2 Product Portfolio 256

14.17.3 Recent Developments 256

14.18 Teva Pharmaceutical 258

14.18.1 Company Overview 258

14.18.1.1 Drivers Explained 259

14.18.1.2 Weaknesses Explained 259

14.18.1.3 Oppurtunities Explained 260

14.18.1.4 Threats Explained 261

14.18.2 Product Portfolio 262

14.18.3 Recent Developments 263

14.19 West Pharmaceutical Services, Inc 264

14.19.1 Company Overview 264

14.19.2 Product Portfolio 265

14.19.3 Recent Developments 266

14.20 Ypsomed Holding Ag 267

14.20.1 Company Overview 267

14.20.2 Product Portfolio 268

14.20.3 Recent Developments 268

15 Related Reports 269


List Of Figure

List Of Figures

Figure 1 North America Injectable Drug Delivery Market: Segmentation 26

Figure 2 North America Injectable Drug Delivery Market: Geographic Scope 27

Figure 3 North America Injectable Drug Delivery Market: Data Triangulation 29

Figure 4 North America Injectable Drug Delivery Market: Research Snapshot 30

Figure 5 North America Injectable Drug Delivery Market: Bottom Up Approach 31

Figure 6 North America Injectable Drug Delivery Market: Top Down Approach 31

Figure 7 North America Injectable Drug Delivery Market: Interview Demographics 32

Figure 8 Figure: Drivers, Restraints, Opportunities, And Challenges Of The Injectable Drug Delivery Market 35

Figure 9 Number Of Needlestick Injuries 40

Figure 10 Technological Development And Increasing Prevalence Of Chronic Diseases Are Expected To Drive The Market For Injectable Drug Delivery In The Forecast Period 2018 To 2025 51

Figure 11 Injectable Drug Delivery Formulation Market Segment Is Expected To Account For The Largest Share Of The North America Injectable Drug Delivery Market In 2018 & 2025 52

Figure 12 North America Is The Highest Growing And Most Profitable Revenue Pockets For Injectable Drug Delivery Manufacturers In The Forecast Period To 2025 53

Figure 13 North America Injectable Drug Delivery Market: By Type, Snapshot 2016 55

Figure 14 North America Injectable Drug Delivery Market: By Application, Snapshot 2017 97

Figure 15 North America Injectable Drug Delivery Market: By Usage Pattern, Snapshot 2017 122

Figure 16 North America Injectable Drug Delivery Market: By Mode Of Administration, Snapshot 2017 127

Figure 17 North America Injectable Drug Delivery Market Dominated By Hospital And Cliinics Segment 132

Figure 18 North America Injectable Drug Deliverymarket: By End-User, Snapshot 2017 133

Figure 19 North America Injectable Drug Delivery Market: By Distribution Channel, Snapshot 2017 138

Figure 20 North America Injectable Drug Delivery Market Snapshot (2017) 141

Figure 21 North America Injectable Drug Delivery Market: Company Share 2017 (%) 205

Figure 22 Becton, Dickinson And Company: Swot (Strength, Weakness, Opportunities And Threats) 206

Figure 23 Becton, Dickinsom And Company: Revenue Analysis 209

Figure 24 Pfizer, Inc.: Swot (Strength, Weakness, Opportunities And Threats) 211

Figure 25 Pfizer, Inc.: Revenue Analysis 214

Figure 26 Baxter International Inc.: Swot (Strength, Weakness, Opportunities And Threats) 217

Figure 27 Baxter International, Inc.: Revenue Analysis 221

Figure 28 Gerresheimer Ag: Revenue Analysis 223

Figure 29 Schott Ag Inc.: Revenue Analysis 225

Figure 30 Alkermes Inc.: Revenue Analysis 227

Figure 31 Antares Pharma: Revenue Analysis 229

Figure 32 Bespak: Revenue Analysis 232

Figure 33 Elcam Medical: Revenue Analysis 234

Figure 34 Eli Lilly And Company: Swot (Strength, Weakness, Opportunities And Threats) 235

Figure 35 Eli Lilly And Company: Revenue Analysis 239

Figure 36 Haselmeier: Revenue Analysis 241

Figure 37 Mylan N.V.: Revenue Analysis 243

Figure 38 Novo Nordisk: Revenue Analysis 245

Figure 39 Owen Mumford Ltd: Revenue Analysis 248

Figure 40 Sandoz International Gmbh: Revenue Analysis 250

Figure 41 Sanofi: Revenue Analysis 252

Figure 42 Terumo Corporation: Revenue Analysis 255

Figure 43 Teva Pharmaceutical: Swot (Strength, Weakness, Opportunities And Threats) 258

Figure 44 Teva Pharmaceutical: Revenue Analysis 262

Figure 45 West Pharmaceutical Services, Inc: Revenue Analysis 265

Figure 46 Ypsomed Holding Ag: Revenue Analysis 267


List Of Table

List Of Tables

Uu

Table 1 Examples Of Technological Advancements ()(2013- 2017) 39

Table 2 List Of Product Recall Drugs 47

Table 3 North America Injectable Drug Delivery Market, By Type, 2016-2025(Usd Million) 56

Table 4 North America Injectable Drug Delivery Devices Market, By Type, 2016-2025 (Usd Million) 57

Table 5 North America Conventional Drug Delivery Market, By Material, 2016-2025 (Usd Million) 60

Table 6 North America Conventional Drug Delivery Market, By Product, 2016-2025 (Usd Million) 61

Table 7 North America Conventional Drug Delivery Market, By Usability, 2016-2025(Usd Million) 63

Table 8 North America Self Injection Devices Market, By Product Type, 2016-2025 (Usd Million) 64

Table 9 North America Needle Free Injector Devices Market, By Product, 2016-2025 (Usd Million) 66

Table 10 North America Needle Free Injector Devices Market, By Technology, 2016- 2025 (Usd Million) 68

Table 11 North America Needle Free Injectors Device Arket, By Usability, 2016-2025 (Usd Million) 69

Table 12 North America Auto Injector Devices Market, By Product, 2016-2025 (Usd Million) 70

Table 13 North America Auto Injector Devices Market, By Technology, 2016-2025 (Usd Million) 71

Table 14 North America Auto Injector Devices Market, By Design, 2016-2025 (Usd Million) 73

Table 15 North America Auto Injectors Device Market, By Usability, 2016-2025 (Usd Million) 74

Table 16 North America Pen Injector Devices Market, By Product, 2016-2025 (Usd Million) 76

Table 17 North America Pen Injector Devices Market, By Design, 2016-2025 (Usd Million) 77

Table 18 North America Pen Injectors Device Market, By Usability, 2016-2025 (Usd Million) 78

Table 19 North America Injectable Drug Delivery Formulation Market, By Type, 2016-2025 (Usd Million) 80

Table 20 List Of Some Of The Lyophilized Formulations 82

Table 21 List Of Some Of The Emulsions 84

Table 22 North America Conventional Drug Delivery Formulation Market, By Product Type, 2016- 2025 (Usd Million) 84

Table 23 North America Novel Drug Delivery Formulation Market, By Product Type,2016-2025 (Usd Million) 85

Table 24 North America Colloidal Novel Drug Delivery Formulation Market, By Product Type, 20156- 2025 (Usd Million) 86

Table 25 List Of Some Of The Niosomes 87

Table 26 List Of Some Of The Liposomes 87

Table 27 List Of Some Of The Polymeric Mixed Micelles Drug Manufacturer 89

Table 28 List Of Nanosuspension Drug Manufacturer 90

Table 29 List Of Some Of The Nanoemulsions/Microemulsions Drug Manufacturer 90

Table 30 List Of Some Of The Solid Lipid Nanoparticles Drug Manufacturer 91

Table 31 North America Nanoparticle Colloidal Drug Delivery Formulation Market, By Product, 2016-2025 (Usd Million) 91

Table 32 List Of Some Of The Microspheres Drug Manufacturer 93

Table 33 North America Microparticles Colloidal Novel Drug Delivery Formulation Market, By Product Type, 20156- 2025 (Usd Million) 93

Table 34 List Of Some Of The First Generation Long Acting Injection 94

Table 35 List Of Some Of The Second Generation Long Acting Injection: 95

Table 36 North America Injectable Drug Delivery Application Market, By Application, 2016-2025 (Usd Million) 98

Table 37 North America Injectable Drug Delivery Application Market, By Hormonal Disorders Type, 2016-2025 (Usd Billion) 105

Table 38 North America Autoimmune Disease Injectable Drug Delivery Application Market, By Autoimmune Disease Type, 2016-2025 (Usd Billion) 112

Table 39 List Of Orphan Disease In India (2010) 114

Table 40 North America Others Injectable Drug Delivery Application Market, By Others Type, 2016-2025 (Usd Billion) 120

Table 41 North Americainjectable Drug Delivery Usage Pattern Market, By Type, 2015-2024 (Usd Million) 125

Table 42 North America Injectable Drug Delivery Market, By Mode Of Administration, 2016-2025 (Usd Million) 130

Table 43 North America Injectable Drug Delivery Market, By End User, 2016- 2025 (Usd Million) 136

Table 44 North America Injectable Drug Delivery Market, By Distribution Channel, 2016-2025 (Usd Million) 140

Table 45 North America Injectable Drug Delivery Market, By Country, 2016-2025 (Usd Million) 142

Table 46 North America Injectable Drug Delivery Market, By Type, 2016-2025 (Usd Million) 142

Table 47 North America Injectable Drug Delivery Devices Market, By Product Type, 2016-2025 (Usd Million) 143

Table 48 North America Conventional Injectable Drug Delivery Device Market, By Material,2016-2025 (Usd Million) 143

Table 49 North America Conventional Injectable Drug Delivery Device Market, By Product Type, 2016-2025 (Usd Million) 144

Table 50 North America Conventional Injectable Drug Delivery Device Market, By Usability, 2016-2025 (Usd Million) 144

Table 51 North America Self Injection Device Market, By Type,2016-2025 (Usd Million) 145

Table 52 North America Needle Free Injectors (Nfi) Device Market, By Product,2016-2025 (Usd Million) 145

Table 53 North America Needle Free Injectors (Nfi) Device Market, By Technology, 2016-2025 (Usd Million) 146

Table 54 North America Needle Free Injectors (Nfi) Device Market, By Usability, 2016-2025 (Usd Million) 146

Table 55 North America Auto Injectorsdevice Market, By Product, 2016-2025 (Usd Million) 147

Table 56 North America Auto Injectors Device Market, By Technology, 2016-2025 (Usd Million) 147

Table 57 North America Auto Injectors Device Market, By Design, 2016-2025 (Usd Million) 148

Table 58 North America Auto Injectors Device Market, By Usability, 2016-2025 (Usd Million) 148

Table 59 North America Pen Injectors Device Market, By Product, 2016-2025 (Usd Million) 149

Table 60 North America Pen Injectors Device Market, By Design,2016- 2025 (Usd Million) 149

Table 61 North America Pen Injectors Device Market, By Usability, 2016-2025 (Usd Million) 150

Table 62 North America Injectable Drug Delivery Formulation Market, By Type, 2016- 2025 (Usd Million) 150

Table 63 North America Conventionaldrug Delivery Formulations, By Product Type 2016-2025 (Usd Million) 151

Table 64 North America Noveldrug Delivery Formulations, By Product Type, 2016-2025 (Usd Million) 151

Table 65 North America Colloidaldispersion Drug Delivery Formulation, By Product Type ,20156- 2025 (Usd Million) 152

Table 66 North America Nanoparticles Colloidal Dispersions Drug Delivery Formulations, By Type, 2016- 2025 (Usd Million) 152

Table 67 North America Micro Particles Drug Delivery Formulations, By Type, 2016- 2025 (Usd Million) 153

Table 68 North America Injectable Drug Delivery Market, By Application, 2016-2025 (Usd Million) 153

Table 69 North America Autoimmune Diseases Injectable Drug Delivery Market, By Autoimmune Disease Type, 2016-2025 (Usd Million) 154

Table 70 North America Hormonal Disorders Injectable Drug Delivery Market, By Hormonal Disorders Type, 2016-2025 (Usd Million) 154

Table 71 North America Others Injectable Drug Delivery Market, By Others Type, 2016-2025 (Usd Million) 155

Table 72 North America Injectable Drug Delivery Market, By Usage Pattern, 2016- 2025 (Usd Million) 155

Table 73 North America Injectable Drug Delivery Market, By Mode Of Administration, 2016- 2025 (Usd Million) 156

Table 74 North America Injectable Drug Delivery Market, By End User, 2016- 2025 (Usd Million) 156

Table 75 North America Injectable Drug Delivery Market, By Distribution Channel, 2016- 2025 (Usd Million) 157

Table 76 U.S. Injectable Drug Delivery Market, By Product Type, 2016-2025 (Usd Million) 158

Table 77 U.S. Injectable Drug Delivery Devices Market, By Product Type, 2016-2025 (Usd Million) 159

Table 78 U.S. Conventional Injectable Drug Delivery Device Market, By Product Type,2016-2025 (Usd Million) 159

Table 79 U.S. Conventional Injectable Drug Delivery Device Market, By Usability, 2016-2025 (Usd Million) 160

Table 80 U.S. Self Injection Device Market, By Type, 2016-2025 (Usd Million) 160

Table 81 U.S. Needle Free Injectors (Nfi) Device Market, By Product,2016-2025 (Usd Million) 161

Table 82 U.S. Needle Free Injectors (Nfi) Device Market, By Technology, 2016-2025 (Usd Million) 161

Table 83 U.S. Needle Free Injectors (Nfi) Device Market, By Usability, 2016-2025 (Usd Million) 162

Table 84 U.S. Auto Injectorsdevice Market, By Product, 2016-2025 (Usd Million) 162

Table 85 U.S. Auto Injectors Device Market, By Technology, 2016-2025 (Usd Million) 163

Table 86 U.S. Auto Injectors Device Market, By Design, 2016-2025 (Usd Million) 163

Table 87 U.S. Auto Injectors Device Market, By Usability, 2016-2025 (Usd Million) 164

Table 88 U.S. Pen Injectors Device Market, By Product, 2016-2025 (Usd Million) 164

Table 89 U.S. Pen Injectors Device Market, By Usability, 2016-2025 (Usd Million) 165

Table 90 U.S. Injectable Drug Delivery Formulation Market, By Product Type, 2016- 2025 (Usd Million) 165

Table 91 U.S. Conventionaldrug Delivery Formulations, By Product Type 2016-2025 (Usd Million) 166

Table 92 U.S. Noveldrug Delivery Formulations, By Product Type 2016-2025 (Usd Million) 166

Table 93 U.S. Colloidaldispersion Drug Delivery Formulation, By Product Type , 2016-2025 (Usd Million) 167

Table 94 U.S. Nanoparticles Colloidal Dispersions Drug Delivery Formulations, By Product Type, 2016- 2025 (Usd Million) 167

Table 95 U.S. Micro Particles Drug Delivery Formulations, By Product Type, 2016- 2025 (Usd Million) 168

Table 96 U.S. Injectable Drug Delivery Market, By Application,2016-2025 (Usd Million) 168

Table 97 U.S. Autoimmune Diseases Injectable Drug Delivery Market, By Autoimmune Disease Type, 20156- 2025 (Usd Million) 169

Table 98 U.S. Hormonal Disorders Injectable Drug Delivery Market, By Hormonal Disorders Type, 2016-2025 (Usd Million) 169

Table 99 U.S. Others Injectable Drug Delivery Market, By Others Type, 2016-2025 (Usd Million) 170

Table 100 U.S. Injectable Drug Delivery Market, By Usage Pattern, 2016- 2025 (Usd Million) 170

Table 101 U.S. Injectable Drug Delivery Market, By Mode Of Administration, 2016- 2025 (Usd Million) 171

Table 102 U.S. Injectable Drug Delivery Market, By End User, 2016- 2025 (Usd Million) 171

Table 103 U.S. Injectable Drug Delivery Market, By Distribution Channel 2016- 2025 (Usd Million) 172

Table 104 Canada Injectable Drug Delivery Market, By Type, 20156- 2025 (Usd Million) 173

Table 105 Canada Injectable Drug Delivery Devices Market, By Product Type, 2016-2025 (Usd Million) 174

Table 106 Canada Conventional Injectable Drug Delivery Device Market, By Material,2016-2025 (Usd Million) 174

Table 107 Canada Conventional Injectable Drug Delivery Device Market, By Product Type,2016-2025 (Usd Million) 175

Table 108 Canada Conventional Injectable Drug Delivery Device Market, By Usability, 2016-2025 (Usd Million) 175

Table 109 Canada Self Injection Device Market, By Type, 2016-2025 (Usd Million) 176

Table 110 Canada Needle Free Injectors (Nfi) Device Market, By Product,2016-2025 (Usd Million) 176

Table 111 Canada Needle Free Injectors (Nfi) Device Market, By Technology, 2016-2025 (Usd Million) 177

Table 112 Canada Needle Free Injectors (Nfi) Device Market, By Usability, 2016-2025 (Usd Million) 177

Table 113 Canada Auto Injectorsdevice Market, By Product, 2016-2025 (Usd Million) 178

Table 114 Canada Auto Injectors Device Market, By Technology, 2016-2025 (Usd Million) 178

Table 115 Canada Auto Injectors Device Market, By Design, 2016-2025 (Usd Million) 179

Table 116 Canada Auto Injectors Device Market, By Usability, 2016-2025 (Usd Million) 179

Table 117 Canada Pen Injectors Device Market, By Product, 2016-2025 (Usd Million) 180

Table 118 Canada Pen Injectors Device Market, By Design, 2016-2025 (Usd Million) 180

Table 119 Canada Pen Injectors Device Market, By Usability, 2016-2025 (Usd Million) 181

Table 120 Canada Injectable Drug Delivery Formulation Market, By Product Type, 2016- 2025 (Usd Million) 181

Table 121 Canada Conventionaldrug Delivery Formulations, By Product Type 2016-2025 (Usd Million) 182

Table 122 Canada Noveldrug Delivery Formulations, By Producttype 2016-2025 (Usd Million) 182

Table 123 Canada Colloidaldispersion Drug Delivery Formulation, By Producttype 2016-2025 (Usd Million) 183

Table 124 Canada Nanoparticles Colloidal Dispersions Drug Delivery Formulations, By Product Type, 2016- 2025 (Usd Million) 183

Table 125 Canada Micro Particles Drug Delivery Formulations, By Product Type, 2016- 2025 (Usd Million) 184

Table 126 Canada Injectable Drug Delivery Market, By Application,2016-2025 (Usd Million) 184

Table 127 Canada Autoimmune Diseases Injectable Drug Delivery Market, By Autoimmune Diseases Type, 2016-2025 (Usd Million) 185

Table 128 Canada Hormonal Disorders Injectable Drug Delivery Market, By Hormonal Disorders Type, 2016-2025 (Usd Million) 185

Table 129 Canada Others Injectable Drug Delivery Market, By Others Type, 2016-2025 (Usd Million) 186

Table 130 Canada Injectable Drug Delivery Market, By Usage Pattern, 2016- 2025 (Usd Million) 186

Table 131 Canada Injectable Drug Delivery Market, By Mode Of Administration, 2016- 2025 (Usd Million) 187

Table 132 Canada Injectable Drug Delivery Market, By End User, 2016- 2025 (Usd Million) 187

Table 133 Canada Injectable Drug Delivery Market, By Distribution Channel 2016- 2025 (Usd Million) 188

Table 134 Mexico Injectable Drug Delivery Market, By Producttype, 2016-2025 (Usd Million) 189

Table 135 Mexico Injectable Drug Delivery Devices Market, By Product Type, 2016-2025 (Usd Million) 190

Table 136 Mexico Conventional Injectable Drug Delivery Device Market, By Material,2016-2025 (Usd Million) 190

Table 137 Mexico Conventional Injectable Drug Delivery Device Market, By Product Type, 2016-2025 (Usd Million) 191

Table 138 Mexico Conventional Injectable Drug Delivery Device Market, By Usability, 2016-2025(Usd Million) 191

Table 139 Mexico Self Injection Device Market, By Type, 2016-2025 (Usd Million) 192

Table 140 Mexico Needle Free Injectors (Nfi) Device Market, By Product,2016-2025 (Usd Million) 192

Table 141 Mexico Needle Free Injectors (Nfi) Device Market, By Technology, 2016-2025 (Usd Million) 193

Table 142 Mexico Needle Free Injectors (Nfi) Device Market, By Usability, 2016-2025 (Usd Million) 193

Table 143 Mexico Auto Injectorsdevice Market, By Product, 2016-2025 (Usd Million) 194

Table 144 Mexico Auto Injectors Device Market, By Technology, 2016-2025 (Usd Million) 194

Table 145 Mexico Auto Injectors Device Market, By Design, 2016-2025 (Usd Million) 195

Table 146 Mexico Auto Injectors Device Market, By Usability, 2016-2025 (Usd Million) 195

Table 147 Mexico Pen Injectors Device Market, By Product, 2016-2025 (Usd Million) 196

Table 148 Mexico Pen Injectors Device Market, By Design, 2016-2025 (Usd Million) 196

Table 149 Mexico Pen Injectors Device Market, By Usability, 2016-2025 (Usd Million) 197

Table 150 Mexico Injectable Drug Delivery Formulation Market, By Product Type, 2016- 2025 (Usd Million) 197

Table 151 Mexico Conventionaldrug Delivery Formulations, By Producttype 2016-2025 (Usd Million) 198

Table 152 Mexico Noveldrug Delivery Formulations, By Product Type 2016-2025 (Usd Million) 198

Table 153 Mexico Colloidaldispersion Drug Delivery Formulation, By Producttype 2015-2024 (Usd Million) 199

Table 154 Mexico Nanoparticles Colloidal Dispersions Drug Delivery Formulations, By Product Type, 2016- 2025 (Usd Million) 199

Table 155 Mexico Micro Particles Drug Delivery Formulations, By Product Type, 2016- 2025 (Usd Million) 200

Table 156 Mexico Injectable Drug Delivery Market, By Application,2016-2025 (Usd Million) 200

Table 157 Mexico Autoimmune Diseases Injectable Drug Delivery Market, By Autoimmune Disease Type, 2016-2025 (Usd Million) 201

Table 158 Mexico Hormonal Disorders Injectable Drug Delivery Market, By Hormonal Disorders Type, 2016-2025 (Usd Million) 201

Table 159 Mexico Others Injectable Drug Delivery Market, By Others Type, 2016-2025 (Usd Million) 202

Table 160 Mexico Injectable Drug Delivery Market, By Usage Pattern, 2016- 2025 (Usd Million) 202

Table 161 Mexico Injectable Drug Delivery Market, By Mode Of Administration, 2016- 2025 (Usd Million) 203

Table 162 Mexico Injectable Drug Delivery Market, By End User, 2016- 2025 (Usd Million) 203

Table 163 Mexico Injectable Drug Delivery Market, By Distribution Channel 2016- 2025 (Usd Million) 204

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Baxter International, Inc.,

Becton Dickinson and Company,

Gerresheimer AG,

Pfizer, Inc.,

Schott AG,

Alkermes Plc.,

Eli Lilly and Company,

Sandoz,

Terumo Corporation,

Teva Pharmaceuticals Industries Ltd.

Ypsomed,

Bespak

North America injectable drug delivery market is expected to reach USD 475,824.35 million by 2025 from USD 173,547.84 million in 2017, at a CAGR of 11.7% in the forecast period 2018 to 2025.

The major factors contributing to the growth of the market includes factors such rising cases of chronic diseases and due to rising demand of self-injection devices. On the other hand needle stick injuries and infections may hinder the growth of the market.

The key market players for North America injectable drug delivery market are listed below:

Baxter International, Inc.,

Becton Dickinson and Company,

Gerresheimer AG,

Pfizer, Inc.,

Schott AG,

Alkermes Plc.,

Eli Lilly and Company,

Sandoz,

Terumo Corporation,

Teva Pharmaceuticals Industries Ltd.

Ypsomed,

Bespak

The market is further segmented into:

Type

Usage Pattern

End-User

Mode of Administration

Distribution Channel

Application

Geography

The North America injectable drug delivery market is segmented on of type, portability, type, product type, application, and usage pattern, mode of administration, end user, distribution channel, and geography. The report provides data for 2016 to 2025, 2017 being the current year while 2018 to 2025 is the forecast period for the report.

The North America injectable drug delivery market is segmented based on type into two notable segments; injectable drug delivery device and injectable drug delivery formulation. Injectable drug delivery device market is segmented into conventional injection devices and self-injection devices. The injectable drug delivery formulation is segmented into conventional drug delivery formulation and novel drug delivery formulation. The Injectable drug delivery market is dominated by formulations with 67.3% market share in 2018, growing at a CAGR of 11.7% and will cross USD 321,636.51 million by 2025.

On the basis of application, the market is segmented into autoimmune disease, hormonal disorders, orphan diseases, oncology and others. The autoimmune diseases segment is further sub segmented based on indications into rheumatoid arthritis, multiple sclerosis, Crohn's disease, psoriasis and others. Hormonal disorders are further segmented into indications such as diabetes, antithrombotic therapy, reproductive health diseases, anemia, osteoporosis and others. The Injectable drug delivery market is dominated by hormonal disorders with 51.3% market share in 2018, growing at a CAGR of 11.6% and will cross USD 243,167.7 million by 2025. However, oncology segment is expected to grow at the highest CAGR of 12.7% in the forecast period, and is expected to reach USD 121,443.5 million in 2025 from USD 40,516.7 million in 2017.

On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern. The Injectable drug delivery market is dominated by curative care with 91.7% market share in 2018, growing at a CAGR of 11.8% and will cross USD 440,541.8 million by 2025.

On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system. The Injectable drug delivery market is dominated by skin with 43.2% market share in 2018, growing with highest CAGR of 12.3% and will cross USD 215,342.4 million by 2025.

On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others. The Injectable drug delivery market is dominated by hospitals & clinics with 64.6% market share in 2018, growing at a CAGR of 11.7% and will cross USD 307,853.9 million by 2025. However, home healthcare settings companies segment is expected to grow at the highest CAGR of 12.3% in the forecast period, and is expected to reach USD 113,830.3 million in 2025 from USD 39,257.1 million in 2017

On the basis of distribution channel, the market is classified into hospital pharmacies, pharmacy store, and direct tender and online pharmacy. The Injectable drug delivery market is dominated by direct tenders with 65.1% market share in 2018, growing the highest CAGR of 11.9% and will cross USD 315,277.4 million by 2025.

Based on geography, the North America injectable drug delivery market is segmented into geographical regions, such as

U.S.

Canada

Mexico

Covered in this report

The report covers the present scenario and the growth prospects of the North America injectable drug delivery market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report

READ MORE

Scope

Table Of Contents

1 Introduction 21

1.1 Overview Of North America Injectable Drug Delivery Market 21

1.2 Currency And Pricing 22

1.3 Limitation 22

1.4 Markets Covered 23

2 Market Segmentation 26

2.1 Markets Covered 26

2.2 Geographic Scope 27

2.3 Years Considered For The Study 28

2.4 Currency And Pricing 28

2.5 Research Methodology 29

2.6 Primary Interviews With Key Opinion Leaders 32

2.7 Secondary Sources 33

2.8 Assumptions 33

3 Market Overview 34

3.1 Drivers 36

3.1.1 Rising Cases Of Chronic Diseases 36

3.1.2 Rising Demand Of Self-Injection Devices 38

3.1.3 Growth Of Biologics Market 38

3.1.4 Technological Advancements And Innovations In Drug Delivery Market 39

3.2 Restraints 40

3.2.1 Needlestick Injuries And Infections 40

3.2.2 High Cost Of Development 41

3.2.3 Strict Regulatory Framework 42

3.3 Opportunity 43

3.3.1 Increasing Demand For Generic And Biosimilar Drugs 43

3.3.1.1 Generics 43

3.3.1.2 Biosimilars 43

3.3.2 Increasing Demand For Contraceptive Injectables 44

3.3.3 Increasing Demand For Self-Administration Of Drugs 45

3.4 Challenges 46

3.4.1 Alternative Route Of Drug Administration 46

3.4.2 Product Recall 47

3.4.3 Stability Of Products 47

3.4.4 Sterility Of Injections 48

4 Executive Summary 49

5 Premium Insights 51

6 North America Injectable Drug Delivery Market, By Type 54

6.1 Overview 55

6.2 Injectable Drug Delivery Devices 56

6.2.1 Conventional Injection Devices 57

6.2.1.1 Conventional Injection Devices, By Material 59

6.2.1.1.1 Glass 59

6.2.1.1.2 Plastic 59

6.2.1.2 Conventional Injection Devices, By Product 60

6.2.1.2.1 Fillable Syringes 60

6.2.1.2.2 Prefilled Syringes 61

6.2.1.3 Conventional Injection Devices, By Usability 62

6.2.1.3.1 Reusable Syringes 62

6.2.1.3.2 Disposable Syringes 62

6.2.2 Self Injection Devices 63

6.2.2.1 Needle Free Injectors (Nfi) 64

6.2.2.2 Needle Free Injectors, By Product 65

6.2.2.2.1 Fillable Needle-Free Injectors 65

6.2.2.2.2 Prefilled Needle-Free Injectors 65

6.2.2.3 Needle Free Injectors, By Technology 66

6.2.2.3.1 Jet Based Needle Free Injectors: 66

6.2.2.3.2 Spring Based Needle Free Injectors: 67

6.2.2.3.3 Laser Based Needle Free Injectors: 67

6.2.2.3.4 Vibration Based Needle Free Injectors: 67

6.2.2.4 Needle Free Injectors, By Usability 68

6.2.2.4.1 Reusable Needle-Free Injectors 68

6.2.2.4.2 Disposable Needle-Free Injectors 68

6.2.2.5 Auto Injectors 69

6.2.2.6 Auto Injectors, By Product 70

6.2.2.6.1 Fillable Auto Injectors 70

6.2.2.6.2 Pre-Filled Autoinjectors 70

6.2.2.7 Auto Injectors, By Technology 71

6.2.2.7.1 Automated Auto Injectors 71

6.2.2.7.2 Manual Auto Injectors 71

6.2.2.8 Auto Injectors, By Design 73

6.2.2.8.1 Standardized Auto Injectors 73

6.2.2.8.2 Automated Autoinjectors 73

6.2.2.9 Auto Injectors, By Usability 74

6.2.2.9.1 Reusable Autoinjectors 74

6.2.2.9.2 Disposable Autoinjectors 74

6.2.2.10 Pen Injectors 75

6.2.2.11 Pen Injectors, By Product 75

6.2.2.11.1 Single Chambered Pen Injectors 75

6.2.2.11.2 Dual Chambered Pen Injectors 76

6.2.2.12 Pen Injectors, By Design 76

6.2.2.12.1 Standard Pen Injectors 76

6.2.2.12.2 Customized Pen Injectors 77

6.2.2.13 Pen Injectors, By Usability 77

6.2.2.13.1 Reusable Pen Injectors 77

6.2.2.13.2 Disposable Pen Injectors 78

6.2.2.14 Wearable Injectors 78

6.2.2.14.1 Other Devices 79

6.3 Injectable Drug Delivery Formulation 80

6.3.1 Conventional Drug Delivery Formulations 81

6.3.1.1 Solutions 81

6.3.1.2 Reconstituted/Lyophilized Formulations 81

6.3.1.3 Suspensions 82

6.3.1.4 Emulsions 83

6.3.2 Novel Drug Delivery Formulations 85

6.3.2.1 Colloidal Dispersions 86

6.3.2.1.1 Niosomes 86

6.3.2.1.2 Liposomes 87

6.3.2.1.3 Polymeric Mixed Micelles 88

6.3.2.1.4 Nanoparticles 89

6.3.2.1.5 Nanosuspensions 89

6.3.2.1.6 Nanoemulsions/Microemulsions 90

6.3.2.1.7 Solid Lipid Nanoparticles 91

6.3.2.2 Microparticles 92

6.3.2.2.1 Microspheres 92

6.3.2.2.2 Microcapsules 93

6.3.2.3 Long Acting Injection Formulation 94

?

7 North America Injectable Drug Delivery Market, By Application 96

7.1 Overview 97

7.2 North America Injectable Drug Delivery Market, By Application 98

7.3 Hormonal Disorders 99

7.3.1 Injectable Drugs For Diabetes 99

7.3.2 Injectable Drugs For Anemia 100

7.3.3 Injectable Drugs For Reproductive Health Disease 102

7.3.4 Injectable Drugs For Antithrombotic/Thrombolytic Therapy 103

7.3.5 Injectable Drugs For Osteoporosis 103

7.3.6 Injectable Drugs For Growth Hormone Disorders (Ghd) 104

7.4 Oncology 106

7.5 Autoimmune Diseases 108

7.5.1 Injectable Drugs For Rheumatoid Arthritis 108

7.5.2 Injectable Drugs For Multiple Sclerosis 109

7.5.3 Injectable Drugs For Crohn'S Diseases 110

7.5.4 Injectable Drugs For Psoriasis 111

7.5.5 Injectable Drugs For Other Autoimmune Diseases 112

7.6 Orphan Disease 113

7.7 Other Applications 115

7.7.1 Injectable Drugs For Pain Management 115

7.7.2 Injectable Drugs For Allergy Treatment 116

7.7.3 Injectable Drugs For Aesthetic Treatments 117

7.7.4 Injectable Drugs For Hepatitis C 118

7.7.5 Injectable Drugs For Hemophilia 119

8 North America Injectable Drug Delivery Market, By Usage Pattern 121

8.1 Overview 122

8.2 Curative Care 123

8.3 Immunizations 124

8.4 Other Usage Pattern 125

9 North America Injectable Drug Delivery Market, By Mode Of Administration 126

9.1 Overview 127

9.2 Skin 128

9.3 Circulatory/ Muskoskeletal 128

9.4 Organs 129

9.5 Central Nervous System 130

?

10 North America Injectable Drug Delivery Market, By End User 131

10.1 Overview 132

10.2 Hospitals And Clinics 134

10.3 Home Healthcare Settings 134

10.4 Research Laboratories 134

10.5 Pharmaceutical And Biotechnological Companies 135

10.6 Other End Users 136

11 North America Injectable Drug Delivery Market, By Distribution Channel 137

11.1 Overview 138

11.1.1 Hospital Pharmacy 139

11.1.2 Pharmacy Stores 139

11.1.3 Direct Tender 139

11.1.4 Online Pharmacy 139

12 North America Injectable Drug Dilivery Market By Geography 141

12.1.1 U.S. Injectable Drug Delivery Market 158

12.1.2 Canada Injectable Drug Delivery Market 173

12.1.3 Mexico Injectable Drug Delivery Market 189

13 North America Injectable Drug Delivery Market, Company Share 205

13.1 Company Share Analysis: North America 205

14 Company Profiles 206

14.1 Becton, Dickinson And Company 206

14.1.1 Company Overview 206

14.1.1.1 Drivers Explained 207

14.1.1.2 Weaknesses Explained 207

14.1.1.3 Oppurtunities Explained 208

14.1.1.4 Threats Explained 208

14.1.2 Product Portfolio 209

14.1.3 Recent Developments 210

14.2 Pfizer 211

14.2.1 Company Overview 211

14.2.1.1 Drivers Explained 212

14.2.1.2 Weaknesses Explained 213

14.2.1.3 Oppurtunities Explained 213

14.2.1.4 Threats Explained 214

14.2.2 Product Portfolio 215

14.2.3 Recent Developments 216

14.3 Baxter International 217

14.3.1 Company Overview 217

14.3.1.1 Drivers Explained 218

14.3.1.2 Weaknesses Explained 219

14.3.1.3 Oppurtunities Explained 219

14.3.1.4 Threats Explained 220

14.3.2 Product Portfolio 221

14.3.3 Recent Developments 222

14.4 Gerresheimer Ag 223

14.4.1 Company Overview 223

14.4.2 Product Portfolio 224

14.4.3 Recent Developments 224

14.5 Schott Ag Inc. 225

14.5.1 Company Overview 225

14.5.2 Product Portfolio 226

14.5.3 Recent Developments 226

14.6 Alkermes Inc. 227

14.6.1 Company Overview 227

14.6.2 Product Portfolio 228

14.6.3 Recent Developments 228

14.7 Antares Pharma 229

14.7.1 Company Overview 229

14.7.2 Product Portfolio 230

14.7.3 Recent Developments 230

14.8 Bespak (Subsidiary Of Consort Medical Company) 232

14.8.1 Company Overview 232

14.8.2 Product Portfolio 233

14.8.3 Recent Developments 233

14.9 Elcam Medical 234

14.9.1 Company Overview 234

14.9.2 Product Portfolio 234

14.9.3 Recent Developments 234

14.10 Eli Lilly And Company 235

14.10.1 Company Overview 235

14.10.1.1 Drivers Explained 236

14.10.1.2 Weaknesses Explained 237

14.10.1.3 Oppurtunities Explained 237

14.10.1.4 Threats Explained 238

14.10.2 Product Portfolio 239

14.10.3 Recent Developments 240

14.11 Haselmeier 241

14.11.1 Company Overview 241

14.11.2 Product Portfolio 241

14.11.3 Recent Developments 242

14.12 Mylan N.V. 243

14.12.1 Company Overview 243

14.12.2 Product Portfolio 243

14.12.3 Recent Developments 244

14.13 Novo Nordisk 245

14.13.1 Company Overview 245

14.13.2 Product Portfolio 246

14.13.3 Recent Developments 247

14.14 Owen Mumford Ltd 248

14.14.1 Company Overview 248

14.14.2 Product Portfolio 249

14.14.3 Recent Developments 249

14.15 Sandoz International Gmbh 250

14.15.1 Company Overview 250

14.15.2 Product Portfolio 251

14.15.3 Recent Developments 251

14.16 Sanofi 252

14.16.1 Company Overview 252

14.16.2 Product Portfolio 253

14.16.3 Recent Developments 254

14.17 Terumo Corporation 255

14.17.1 Company Overview 255

14.17.2 Product Portfolio 256

14.17.3 Recent Developments 256

14.18 Teva Pharmaceutical 258

14.18.1 Company Overview 258

14.18.1.1 Drivers Explained 259

14.18.1.2 Weaknesses Explained 259

14.18.1.3 Oppurtunities Explained 260

14.18.1.4 Threats Explained 261

14.18.2 Product Portfolio 262

14.18.3 Recent Developments 263

14.19 West Pharmaceutical Services, Inc 264

14.19.1 Company Overview 264

14.19.2 Product Portfolio 265

14.19.3 Recent Developments 266

14.20 Ypsomed Holding Ag 267

14.20.1 Company Overview 267

14.20.2 Product Portfolio 268

14.20.3 Recent Developments 268

15 Related Reports 269


List Of Figure

List Of Figures

Figure 1 North America Injectable Drug Delivery Market: Segmentation 26

Figure 2 North America Injectable Drug Delivery Market: Geographic Scope 27

Figure 3 North America Injectable Drug Delivery Market: Data Triangulation 29

Figure 4 North America Injectable Drug Delivery Market: Research Snapshot 30

Figure 5 North America Injectable Drug Delivery Market: Bottom Up Approach 31

Figure 6 North America Injectable Drug Delivery Market: Top Down Approach 31

Figure 7 North America Injectable Drug Delivery Market: Interview Demographics 32

Figure 8 Figure: Drivers, Restraints, Opportunities, And Challenges Of The Injectable Drug Delivery Market 35

Figure 9 Number Of Needlestick Injuries 40

Figure 10 Technological Development And Increasing Prevalence Of Chronic Diseases Are Expected To Drive The Market For Injectable Drug Delivery In The Forecast Period 2018 To 2025 51

Figure 11 Injectable Drug Delivery Formulation Market Segment Is Expected To Account For The Largest Share Of The North America Injectable Drug Delivery Market In 2018 & 2025 52

Figure 12 North America Is The Highest Growing And Most Profitable Revenue Pockets For Injectable Drug Delivery Manufacturers In The Forecast Period To 2025 53

Figure 13 North America Injectable Drug Delivery Market: By Type, Snapshot 2016 55

Figure 14 North America Injectable Drug Delivery Market: By Application, Snapshot 2017 97

Figure 15 North America Injectable Drug Delivery Market: By Usage Pattern, Snapshot 2017 122

Figure 16 North America Injectable Drug Delivery Market: By Mode Of Administration, Snapshot 2017 127

Figure 17 North America Injectable Drug Delivery Market Dominated By Hospital And Cliinics Segment 132

Figure 18 North America Injectable Drug Deliverymarket: By End-User, Snapshot 2017 133

Figure 19 North America Injectable Drug Delivery Market: By Distribution Channel, Snapshot 2017 138

Figure 20 North America Injectable Drug Delivery Market Snapshot (2017) 141

Figure 21 North America Injectable Drug Delivery Market: Company Share 2017 (%) 205

Figure 22 Becton, Dickinson And Company: Swot (Strength, Weakness, Opportunities And Threats) 206

Figure 23 Becton, Dickinsom And Company: Revenue Analysis 209

Figure 24 Pfizer, Inc.: Swot (Strength, Weakness, Opportunities And Threats) 211

Figure 25 Pfizer, Inc.: Revenue Analysis 214

Figure 26 Baxter International Inc.: Swot (Strength, Weakness, Opportunities And Threats) 217

Figure 27 Baxter International, Inc.: Revenue Analysis 221

Figure 28 Gerresheimer Ag: Revenue Analysis 223

Figure 29 Schott Ag Inc.: Revenue Analysis 225

Figure 30 Alkermes Inc.: Revenue Analysis 227

Figure 31 Antares Pharma: Revenue Analysis 229

Figure 32 Bespak: Revenue Analysis 232

Figure 33 Elcam Medical: Revenue Analysis 234

Figure 34 Eli Lilly And Company: Swot (Strength, Weakness, Opportunities And Threats) 235

Figure 35 Eli Lilly And Company: Revenue Analysis 239

Figure 36 Haselmeier: Revenue Analysis 241

Figure 37 Mylan N.V.: Revenue Analysis 243

Figure 38 Novo Nordisk: Revenue Analysis 245

Figure 39 Owen Mumford Ltd: Revenue Analysis 248

Figure 40 Sandoz International Gmbh: Revenue Analysis 250

Figure 41 Sanofi: Revenue Analysis 252

Figure 42 Terumo Corporation: Revenue Analysis 255

Figure 43 Teva Pharmaceutical: Swot (Strength, Weakness, Opportunities And Threats) 258

Figure 44 Teva Pharmaceutical: Revenue Analysis 262

Figure 45 West Pharmaceutical Services, Inc: Revenue Analysis 265

Figure 46 Ypsomed Holding Ag: Revenue Analysis 267


List Of Table

List Of Tables

Uu

Table 1 Examples Of Technological Advancements ()(2013- 2017) 39

Table 2 List Of Product Recall Drugs 47

Table 3 North America Injectable Drug Delivery Market, By Type, 2016-2025(Usd Million) 56

Table 4 North America Injectable Drug Delivery Devices Market, By Type, 2016-2025 (Usd Million) 57

Table 5 North America Conventional Drug Delivery Market, By Material, 2016-2025 (Usd Million) 60

Table 6 North America Conventional Drug Delivery Market, By Product, 2016-2025 (Usd Million) 61

Table 7 North America Conventional Drug Delivery Market, By Usability, 2016-2025(Usd Million) 63

Table 8 North America Self Injection Devices Market, By Product Type, 2016-2025 (Usd Million) 64

Table 9 North America Needle Free Injector Devices Market, By Product, 2016-2025 (Usd Million) 66

Table 10 North America Needle Free Injector Devices Market, By Technology, 2016- 2025 (Usd Million) 68

Table 11 North America Needle Free Injectors Device Arket, By Usability, 2016-2025 (Usd Million) 69

Table 12 North America Auto Injector Devices Market, By Product, 2016-2025 (Usd Million) 70

Table 13 North America Auto Injector Devices Market, By Technology, 2016-2025 (Usd Million) 71

Table 14 North America Auto Injector Devices Market, By Design, 2016-2025 (Usd Million) 73

Table 15 North America Auto Injectors Device Market, By Usability, 2016-2025 (Usd Million) 74

Table 16 North America Pen Injector Devices Market, By Product, 2016-2025 (Usd Million) 76

Table 17 North America Pen Injector Devices Market, By Design, 2016-2025 (Usd Million) 77

Table 18 North America Pen Injectors Device Market, By Usability, 2016-2025 (Usd Million) 78

Table 19 North America Injectable Drug Delivery Formulation Market, By Type, 2016-2025 (Usd Million) 80

Table 20 List Of Some Of The Lyophilized Formulations 82

Table 21 List Of Some Of The Emulsions 84

Table 22 North America Conventional Drug Delivery Formulation Market, By Product Type, 2016- 2025 (Usd Million) 84

Table 23 North America Novel Drug Delivery Formulation Market, By Product Type,2016-2025 (Usd Million) 85

Table 24 North America Colloidal Novel Drug Delivery Formulation Market, By Product Type, 20156- 2025 (Usd Million) 86

Table 25 List Of Some Of The Niosomes 87

Table 26 List Of Some Of The Liposomes 87

Table 27 List Of Some Of The Polymeric Mixed Micelles Drug Manufacturer 89

Table 28 List Of Nanosuspension Drug Manufacturer 90

Table 29 List Of Some Of The Nanoemulsions/Microemulsions Drug Manufacturer 90

Table 30 List Of Some Of The Solid Lipid Nanoparticles Drug Manufacturer 91

Table 31 North America Nanoparticle Colloidal Drug Delivery Formulation Market, By Product, 2016-2025 (Usd Million) 91

Table 32 List Of Some Of The Microspheres Drug Manufacturer 93

Table 33 North America Microparticles Colloidal Novel Drug Delivery Formulation Market, By Product Type, 20156- 2025 (Usd Million) 93

Table 34 List Of Some Of The First Generation Long Acting Injection 94

Table 35 List Of Some Of The Second Generation Long Acting Injection: 95

Table 36 North America Injectable Drug Delivery Application Market, By Application, 2016-2025 (Usd Million) 98

Table 37 North America Injectable Drug Delivery Application Market, By Hormonal Disorders Type, 2016-2025 (Usd Billion) 105

Table 38 North America Autoimmune Disease Injectable Drug Delivery Application Market, By Autoimmune Disease Type, 2016-2025 (Usd Billion) 112

Table 39 List Of Orphan Disease In India (2010) 114

Table 40 North America Others Injectable Drug Delivery Application Market, By Others Type, 2016-2025 (Usd Billion) 120

Table 41 North Americainjectable Drug Delivery Usage Pattern Market, By Type, 2015-2024 (Usd Million) 125

Table 42 North America Injectable Drug Delivery Market, By Mode Of Administration, 2016-2025 (Usd Million) 130

Table 43 North America Injectable Drug Delivery Market, By End User, 2016- 2025 (Usd Million) 136

Table 44 North America Injectable Drug Delivery Market, By Distribution Channel, 2016-2025 (Usd Million) 140

Table 45 North America Injectable Drug Delivery Market, By Country, 2016-2025 (Usd Million) 142

Table 46 North America Injectable Drug Delivery Market, By Type, 2016-2025 (Usd Million) 142

Table 47 North America Injectable Drug Delivery Devices Market, By Product Type, 2016-2025 (Usd Million) 143

Table 48 North America Conventional Injectable Drug Delivery Device Market, By Material,2016-2025 (Usd Million) 143

Table 49 North America Conventional Injectable Drug Delivery Device Market, By Product Type, 2016-2025 (Usd Million) 144

Table 50 North America Conventional Injectable Drug Delivery Device Market, By Usability, 2016-2025 (Usd Million) 144

Table 51 North America Self Injection Device Market, By Type,2016-2025 (Usd Million) 145

Table 52 North America Needle Free Injectors (Nfi) Device Market, By Product,2016-2025 (Usd Million) 145

Table 53 North America Needle Free Injectors (Nfi) Device Market, By Technology, 2016-2025 (Usd Million) 146

Table 54 North America Needle Free Injectors (Nfi) Device Market, By Usability, 2016-2025 (Usd Million) 146

Table 55 North America Auto Injectorsdevice Market, By Product, 2016-2025 (Usd Million) 147

Table 56 North America Auto Injectors Device Market, By Technology, 2016-2025 (Usd Million) 147

Table 57 North America Auto Injectors Device Market, By Design, 2016-2025 (Usd Million) 148

Table 58 North America Auto Injectors Device Market, By Usability, 2016-2025 (Usd Million) 148

Table 59 North America Pen Injectors Device Market, By Product, 2016-2025 (Usd Million) 149

Table 60 North America Pen Injectors Device Market, By Design,2016- 2025 (Usd Million) 149

Table 61 North America Pen Injectors Device Market, By Usability, 2016-2025 (Usd Million) 150

Table 62 North America Injectable Drug Delivery Formulation Market, By Type, 2016- 2025 (Usd Million) 150

Table 63 North America Conventionaldrug Delivery Formulations, By Product Type 2016-2025 (Usd Million) 151

Table 64 North America Noveldrug Delivery Formulations, By Product Type, 2016-2025 (Usd Million) 151

Table 65 North America Colloidaldispersion Drug Delivery Formulation, By Product Type ,20156- 2025 (Usd Million) 152

Table 66 North America Nanoparticles Colloidal Dispersions Drug Delivery Formulations, By Type, 2016- 2025 (Usd Million) 152

Table 67 North America Micro Particles Drug Delivery Formulations, By Type, 2016- 2025 (Usd Million) 153

Table 68 North America Injectable Drug Delivery Market, By Application, 2016-2025 (Usd Million) 153

Table 69 North America Autoimmune Diseases Injectable Drug Delivery Market, By Autoimmune Disease Type, 2016-2025 (Usd Million) 154

Table 70 North America Hormonal Disorders Injectable Drug Delivery Market, By Hormonal Disorders Type, 2016-2025 (Usd Million) 154

Table 71 North America Others Injectable Drug Delivery Market, By Others Type, 2016-2025 (Usd Million) 155

Table 72 North America Injectable Drug Delivery Market, By Usage Pattern, 2016- 2025 (Usd Million) 155

Table 73 North America Injectable Drug Delivery Market, By Mode Of Administration, 2016- 2025 (Usd Million) 156

Table 74 North America Injectable Drug Delivery Market, By End User, 2016- 2025 (Usd Million) 156

Table 75 North America Injectable Drug Delivery Market, By Distribution Channel, 2016- 2025 (Usd Million) 157

Table 76 U.S. Injectable Drug Delivery Market, By Product Type, 2016-2025 (Usd Million) 158

Table 77 U.S. Injectable Drug Delivery Devices Market, By Product Type, 2016-2025 (Usd Million) 159

Table 78 U.S. Conventional Injectable Drug Delivery Device Market, By Product Type,2016-2025 (Usd Million) 159

Table 79 U.S. Conventional Injectable Drug Delivery Device Market, By Usability, 2016-2025 (Usd Million) 160

Table 80 U.S. Self Injection Device Market, By Type, 2016-2025 (Usd Million) 160

Table 81 U.S. Needle Free Injectors (Nfi) Device Market, By Product,2016-2025 (Usd Million) 161

Table 82 U.S. Needle Free Injectors (Nfi) Device Market, By Technology, 2016-2025 (Usd Million) 161

Table 83 U.S. Needle Free Injectors (Nfi) Device Market, By Usability, 2016-2025 (Usd Million) 162

Table 84 U.S. Auto Injectorsdevice Market, By Product, 2016-2025 (Usd Million) 162

Table 85 U.S. Auto Injectors Device Market, By Technology, 2016-2025 (Usd Million) 163

Table 86 U.S. Auto Injectors Device Market, By Design, 2016-2025 (Usd Million) 163

Table 87 U.S. Auto Injectors Device Market, By Usability, 2016-2025 (Usd Million) 164

Table 88 U.S. Pen Injectors Device Market, By Product, 2016-2025 (Usd Million) 164

Table 89 U.S. Pen Injectors Device Market, By Usability, 2016-2025 (Usd Million) 165

Table 90 U.S. Injectable Drug Delivery Formulation Market, By Product Type, 2016- 2025 (Usd Million) 165

Table 91 U.S. Conventionaldrug Delivery Formulations, By Product Type 2016-2025 (Usd Million) 166

Table 92 U.S. Noveldrug Delivery Formulations, By Product Type 2016-2025 (Usd Million) 166

Table 93 U.S. Colloidaldispersion Drug Delivery Formulation, By Product Type , 2016-2025 (Usd Million) 167

Table 94 U.S. Nanoparticles Colloidal Dispersions Drug Delivery Formulations, By Product Type, 2016- 2025 (Usd Million) 167

Table 95 U.S. Micro Particles Drug Delivery Formulations, By Product Type, 2016- 2025 (Usd Million) 168

Table 96 U.S. Injectable Drug Delivery Market, By Application,2016-2025 (Usd Million) 168

Table 97 U.S. Autoimmune Diseases Injectable Drug Delivery Market, By Autoimmune Disease Type, 20156- 2025 (Usd Million) 169

Table 98 U.S. Hormonal Disorders Injectable Drug Delivery Market, By Hormonal Disorders Type, 2016-2025 (Usd Million) 169

Table 99 U.S. Others Injectable Drug Delivery Market, By Others Type, 2016-2025 (Usd Million) 170

Table 100 U.S. Injectable Drug Delivery Market, By Usage Pattern, 2016- 2025 (Usd Million) 170

Table 101 U.S. Injectable Drug Delivery Market, By Mode Of Administration, 2016- 2025 (Usd Million) 171

Table 102 U.S. Injectable Drug Delivery Market, By End User, 2016- 2025 (Usd Million) 171

Table 103 U.S. Injectable Drug Delivery Market, By Distribution Channel 2016- 2025 (Usd Million) 172

Table 104 Canada Injectable Drug Delivery Market, By Type, 20156- 2025 (Usd Million) 173

Table 105 Canada Injectable Drug Delivery Devices Market, By Product Type, 2016-2025 (Usd Million) 174

Table 106 Canada Conventional Injectable Drug Delivery Device Market, By Material,2016-2025 (Usd Million) 174

Table 107 Canada Conventional Injectable Drug Delivery Device Market, By Product Type,2016-2025 (Usd Million) 175

Table 108 Canada Conventional Injectable Drug Delivery Device Market, By Usability, 2016-2025 (Usd Million) 175

Table 109 Canada Self Injection Device Market, By Type, 2016-2025 (Usd Million) 176

Table 110 Canada Needle Free Injectors (Nfi) Device Market, By Product,2016-2025 (Usd Million) 176

Table 111 Canada Needle Free Injectors (Nfi) Device Market, By Technology, 2016-2025 (Usd Million) 177

Table 112 Canada Needle Free Injectors (Nfi) Device Market, By Usability, 2016-2025 (Usd Million) 177

Table 113 Canada Auto Injectorsdevice Market, By Product, 2016-2025 (Usd Million) 178

Table 114 Canada Auto Injectors Device Market, By Technology, 2016-2025 (Usd Million) 178

Table 115 Canada Auto Injectors Device Market, By Design, 2016-2025 (Usd Million) 179

Table 116 Canada Auto Injectors Device Market, By Usability, 2016-2025 (Usd Million) 179

Table 117 Canada Pen Injectors Device Market, By Product, 2016-2025 (Usd Million) 180

Table 118 Canada Pen Injectors Device Market, By Design, 2016-2025 (Usd Million) 180

Table 119 Canada Pen Injectors Device Market, By Usability, 2016-2025 (Usd Million) 181

Table 120 Canada Injectable Drug Delivery Formulation Market, By Product Type, 2016- 2025 (Usd Million) 181

Table 121 Canada Conventionaldrug Delivery Formulations, By Product Type 2016-2025 (Usd Million) 182

Table 122 Canada Noveldrug Delivery Formulations, By Producttype 2016-2025 (Usd Million) 182

Table 123 Canada Colloidaldispersion Drug Delivery Formulation, By Producttype 2016-2025 (Usd Million) 183

Table 124 Canada Nanoparticles Colloidal Dispersions Drug Delivery Formulations, By Product Type, 2016- 2025 (Usd Million) 183

Table 125 Canada Micro Particles Drug Delivery Formulations, By Product Type, 2016- 2025 (Usd Million) 184

Table 126 Canada Injectable Drug Delivery Market, By Application,2016-2025 (Usd Million) 184

Table 127 Canada Autoimmune Diseases Injectable Drug Delivery Market, By Autoimmune Diseases Type, 2016-2025 (Usd Million) 185

Table 128 Canada Hormonal Disorders Injectable Drug Delivery Market, By Hormonal Disorders Type, 2016-2025 (Usd Million) 185

Table 129 Canada Others Injectable Drug Delivery Market, By Others Type, 2016-2025 (Usd Million) 186

Table 130 Canada Injectable Drug Delivery Market, By Usage Pattern, 2016- 2025 (Usd Million) 186

Table 131 Canada Injectable Drug Delivery Market, By Mode Of Administration, 2016- 2025 (Usd Million) 187

Table 132 Canada Injectable Drug Delivery Market, By End User, 2016- 2025 (Usd Million) 187

Table 133 Canada Injectable Drug Delivery Market, By Distribution Channel 2016- 2025 (Usd Million) 188

Table 134 Mexico Injectable Drug Delivery Market, By Producttype, 2016-2025 (Usd Million) 189

Table 135 Mexico Injectable Drug Delivery Devices Market, By Product Type, 2016-2025 (Usd Million) 190

Table 136 Mexico Conventional Injectable Drug Delivery Device Market, By Material,2016-2025 (Usd Million) 190

Table 137 Mexico Conventional Injectable Drug Delivery Device Market, By Product Type, 2016-2025 (Usd Million) 191

Table 138 Mexico Conventional Injectable Drug Delivery Device Market, By Usability, 2016-2025(Usd Million) 191

Table 139 Mexico Self Injection Device Market, By Type, 2016-2025 (Usd Million) 192

Table 140 Mexico Needle Free Injectors (Nfi) Device Market, By Product,2016-2025 (Usd Million) 192

Table 141 Mexico Needle Free Injectors (Nfi) Device Market, By Technology, 2016-2025 (Usd Million) 193

Table 142 Mexico Needle Free Injectors (Nfi) Device Market, By Usability, 2016-2025 (Usd Million) 193

Table 143 Mexico Auto Injectorsdevice Market, By Product, 2016-2025 (Usd Million) 194

Table 144 Mexico Auto Injectors Device Market, By Technology, 2016-2025 (Usd Million) 194

Table 145 Mexico Auto Injectors Device Market, By Design, 2016-2025 (Usd Million) 195

Table 146 Mexico Auto Injectors Device Market, By Usability, 2016-2025 (Usd Million) 195

Table 147 Mexico Pen Injectors Device Market, By Product, 2016-2025 (Usd Million) 196

Table 148 Mexico Pen Injectors Device Market, By Design, 2016-2025 (Usd Million) 196

Table 149 Mexico Pen Injectors Device Market, By Usability, 2016-2025 (Usd Million) 197

Table 150 Mexico Injectable Drug Delivery Formulation Market, By Product Type, 2016- 2025 (Usd Million) 197

Table 151 Mexico Conventionaldrug Delivery Formulations, By Producttype 2016-2025 (Usd Million) 198

Table 152 Mexico Noveldrug Delivery Formulations, By Product Type 2016-2025 (Usd Million) 198

Table 153 Mexico Colloidaldispersion Drug Delivery Formulation, By Producttype 2015-2024 (Usd Million) 199

Table 154 Mexico Nanoparticles Colloidal Dispersions Drug Delivery Formulations, By Product Type, 2016- 2025 (Usd Million) 199

Table 155 Mexico Micro Particles Drug Delivery Formulations, By Product Type, 2016- 2025 (Usd Million) 200

Table 156 Mexico Injectable Drug Delivery Market, By Application,2016-2025 (Usd Million) 200

Table 157 Mexico Autoimmune Diseases Injectable Drug Delivery Market, By Autoimmune Disease Type, 2016-2025 (Usd Million) 201

Table 158 Mexico Hormonal Disorders Injectable Drug Delivery Market, By Hormonal Disorders Type, 2016-2025 (Usd Million) 201

Table 159 Mexico Others Injectable Drug Delivery Market, By Others Type, 2016-2025 (Usd Million) 202

Table 160 Mexico Injectable Drug Delivery Market, By Usage Pattern, 2016- 2025 (Usd Million) 202

Table 161 Mexico Injectable Drug Delivery Market, By Mode Of Administration, 2016- 2025 (Usd Million) 203

Table 162 Mexico Injectable Drug Delivery Market, By End User, 2016- 2025 (Usd Million) 203

Table 163 Mexico Injectable Drug Delivery Market, By Distribution Channel 2016- 2025 (Usd Million) 204

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

Baxter International, Inc.,

Becton Dickinson and Company,

Gerresheimer AG,

Pfizer, Inc.,

Schott AG,

Alkermes Plc.,

Eli Lilly and Company,

Sandoz,

Terumo Corporation,

Teva Pharmaceuticals Industries Ltd.

Ypsomed,

Bespak